Mistral Percutaneous Tricuspid Valve Durable Repair Pivotal Study

NAUnknownINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

June 21, 2021

Primary Completion Date

March 1, 2024

Study Completion Date

September 1, 2025

Conditions
Tricuspid Valve Regurgitation
Interventions
DEVICE

Mistral Procedure

"The Mistral is an investigational device intended for percutaneous trans-catheter repair in high risk for surgery individuals suffering from functional Tricuspid Regurgitation (TR).~The device system is to be used only in accordance with the approved Investigational Plan on subjects who have signed an informed consent form. Device use is limited to the approved study investigators."

Trial Locations (1)

Unknown

RECRUITING

Wolfson Medical Center, Holon

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mitralix

INDUSTRY